Showing results (31-40 of 927) with videos related to
Sort By:
Pageof 93
Advances in Alcohol & Substance Abuse|January 1, 1986
The clinical pharmacology of pentazocine and tripelennamine (T's and Blues)W R Lange, D R JasinskiBritish Journal of Addiction|December 1, 1991
Drug discrimination methods in human drug abuse liability evaluationK L PrestonThe Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
l-alpha-Acetylmethadol, l-alpha-acetyl-N-normethadol and l-alpha-acetyl-N,N-dinormethadol: comparisons with morphine and methadone in suppression of the opioid withdrawal syndrome in the dogD B Vaupel, D R JasinskiNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1994
Buprenorphine reduces cerebral glucose metabolism in polydrug abusersS L Walsh, S F Gilson, D R Jasinski, et al.Pharmacology, Biochemistry, and Behavior|November 1, 1983
Cigarette smokers self-administer intravenous nicotineJ E Henningfield, K Miyasato, D R JasinskiThe Journal of Pharmacology and Experimental Therapeutics|July 1, 1985
Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotineJ E Henningfield, K Miyasato, D R JasinskiClinical Pharmacology and Therapeutics|July 1, 1984
Electroencephalographic and behavioral correlates of buprenorphine administrationS E Lukas, D R Jasinski, R E JohnsonAIDS Care|July 15, 2003
Highly active antiretroviral therapy outcomes in a primary care clinicD A Rastegar, M I Fingerhood, D R JasinskiClinical Pharmacology and Therapeutics|March 1, 1975
Etorphine in man. I. Subjective effects and suppression of morphine abstinenceD R Jasinski, J D Griffith, C B CarrPageof 93